Alfabs Australia Ltd
ASX:AAL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.335
0.54
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one AAL stock under the Base Case scenario is 0.743 AUD. Compared to the current market price of 0.465 AUD, Alfabs Australia Ltd is Undervalued by 37%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Alfabs Australia Ltd.
| FI |
M
|
Metso Oyj
OMXH:METSO
|
|
| KR |
H
|
HD Hyundai Marine Solution Co Ltd
KRX:443060
|
|
| SG |
|
Seatrium Limited
SGX:5E2
|
|
| ID |
V
|
VKTR Teknologi Mobilitas Tbk PT
IDX:VKTR
|
|
| JP |
M
|
Mitsui E&S Co Ltd
SWB:MU1
|
|
| IN |
T
|
Titagarh Rail Systems Ltd
NSE:TITAGARH
|
|
| RU |
|
NPK OVK PAO
MOEX:UWGN
|
|
| CN |
B
|
Beijing Tianma Intelligent Control Technology Co Ltd
SSE:688570
|
|
| DE |
J
|
Jost Werke SE
SWB:JST
|
|
| IN |
|
Balu Forge Industries Ltd
BSE:531112
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Alfabs Australia Ltd
Balance Sheet Decomposition
Alfabs Australia Ltd
| Current Assets | 39m |
| Cash & Short-Term Investments | 8.2m |
| Receivables | 20m |
| Other Current Assets | 10.9m |
| Non-Current Assets | 92.8m |
| PP&E | 89.1m |
| Intangibles | 239.8k |
| Other Non-Current Assets | 3.5m |
| Current Liabilities | 34.8m |
| Accounts Payable | 14.6m |
| Other Current Liabilities | 20.2m |
| Non-Current Liabilities | 32.1m |
| Long-Term Debt | 24m |
| Other Non-Current Liabilities | 8.2m |
Free Cash Flow Analysis
Alfabs Australia Ltd
| AUD | |
| Free Cash Flow | AUD |
Earnings Waterfall
Alfabs Australia Ltd
|
Revenue
|
95.7m
AUD
|
|
Cost of Revenue
|
-27m
AUD
|
|
Gross Profit
|
68.6m
AUD
|
|
Operating Expenses
|
-51.4m
AUD
|
|
Operating Income
|
17.2m
AUD
|
|
Other Expenses
|
-5m
AUD
|
|
Net Income
|
12.2m
AUD
|
AAL Profitability Score
Profitability Due Diligence
Alfabs Australia Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Alfabs Australia Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
AAL Solvency Score
Solvency Due Diligence
Alfabs Australia Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Score
Alfabs Australia Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AAL Price Targets Summary
Alfabs Australia Ltd
According to Wall Street analysts, the average 1-year price target for AAL is 0.561 AUD with a low forecast of 0.556 AUD and a high forecast of 0.578 AUD.
Dividends
Current shareholder yield for AAL is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one AAL stock under the Base Case scenario is 0.743 AUD.
Compared to the current market price of 0.465 AUD, Alfabs Australia Ltd is Undervalued by 37%.